pd 145065 has been researched along with transforming growth factor alpha in 1 studies
| Studies (pd 145065) | Trials (pd 145065) | Recent Studies (post-2010) (pd 145065) | Studies (transforming growth factor alpha) | Trials (transforming growth factor alpha) | Recent Studies (post-2010) (transforming growth factor alpha) |
|---|---|---|---|---|---|
| 76 | 1 | 5 | 4,301 | 44 | 623 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engele, J; Figiel, M; Rozyczka, J | 1 |
1 other study(ies) available for pd 145065 and transforming growth factor alpha
| Article | Year |
|---|---|
Endothelins negatively regulate glial glutamate transporter expression.
Topics: Amino Acid Transport System X-AG; Analysis of Variance; Animals; Animals, Newborn; Blotting, Western; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Endothelins; Enzyme Inhibitors; Epidermal Growth Factor; Excitatory Amino Acid Transporter 2; Gene Expression Regulation; Isoquinolines; Nerve Growth Factors; Neuroglia; Neuropeptides; Neurotransmitter Agents; Oligopeptides; Peptide Fragments; Pituitary Adenylate Cyclase-Activating Polypeptide; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Transforming Growth Factor alpha | 2004 |